Difference between revisions of "QIBA Collaborations"

From QIBA Wiki
Jump to navigation Jump to search
 
(29 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
==Collaborative Efforts==
 
==Collaborative Efforts==
  
* [https://www.myesr.org/about/organisation/statutory-committees/research-committee '''European Imaging Biomarkers Alliance (EIBALL)'''] - European Society of Radiology (ESR)
+
QIBA is grateful for the support of our collaborators.
  
* [http://www.radiology.jp/j-qiba/english/index.html '''Japan Quantitative Imaging Biomarker Alliance (J-QIBA)''']
+
*Our society partners help QIBA with the development and implementation of quantitative imaging biomarkers, which are essential to precision medicine and AI tools.
 +
*The companies offer conformance testing services to help Profile users achieve high-quality quantitative imaging results.
  
* [https://preventcancer.org/ '''Prevent Cancer Foundation'''] [[Image:Prevent Cancer Foundation.png|80px]]
+
We work together to provide efficient and validated methods for quantifying biomedical imaging results necessary for optimal patient care, clinical research, and new therapy development.
** [[Media:March-April2018_PCF_Newsletter_LungCancerTimeline.pdf|March/April 2018 Prevent Cancer Foundation Newsletter]]
 
  
* [https://medium.com/cancer-moonshot '''Cancer Moonshot''']  [[Image:Cancer Moonshot.jpg|80px]]
 
** RSNA/QIBA is very pleased to announce two QIBA Profiles have been referenced and supported by the Federal Cancer Moonshot Initiative as ways to advance research and outcomes.
 
** The FDG-PET/CT and CT Volumetry Profiles have been submitted as the most advanced Profiles to-date.  Our sincerest appreciation to all of the QIBA participants who helped us arrive at this important milestone.
 
  
 +
 +
 +
:[[Image:logos-2.png|800px]]
 +
 +
 +
 +
==Collaboration Highlights==
 +
*EARL II Pilot Study - Ongoing study to assess international imaging site conformance to the QIBA FDG-PET/CT Profile -August 2022
 +
*RadSite Pilot Study - Ongoing study to assess accredited imaging site conformance to the QIBA FDG-PET/CT Profile - August 2022
 +
 +
*The QIBA PET Amyloid Profile has advanced to Stage 3 (Clinically Feasible), and can be found on the QIBA Profiles page: https://qibawiki.rsna.org/index.php/Profiles
 +
 +
 +
{| style="width:80%" border="1" cellpadding="2"
 +
!<font color="green">'''Organization'''</font>
 +
!<font color="green">'''link'''</font>
 +
 +
|-
 +
|'''Accumetra'''
 +
|https://accumetra.com/
 +
|-
 +
|'''AIUM - American Institute of Ultrasound in Medicine'''
 +
|https://www.aium.org/
 +
|-
 +
|'''CaliberMRI'''
 +
|https://qmri.com/
 +
|-
 +
|'''EARL, ''Research4Life'', under the umbrella of the European Association of Nuclear Medicine (EANM)'''
 +
|https://www.eanm.org/earl-research4life/
 +
|-
 +
|'''EIBALL - European Imaging Biomarkers Alliance, European Society of Radiology (ESR)'''
 +
|https://www.myesr.org/about/organisation/statutory-committees/research-committee
 +
|-
 +
|'''EIBIR - European Institute for Biomedical Imaging'''
 +
|https://www.eibir.org/
 +
|-
 +
|'''Invicro'''
 +
|https://invicro.com/
 +
|-
 +
|'''ISMRM - International Society for Magnetic Resonance in Medicine'''
 +
|https://www.ismrm.org/
 +
|-
 +
|'''Japan Quantitative Imaging Biomarker Alliance (J-QIBA), a part of the Japan Radiological Society'''
 +
|http://www.radiology.jp/j-qiba/english/index.html
 +
|-
 +
|'''Prevent Cancer Foundation'''
 +
|https://www.preventcancer.org/
 +
|-
 +
|'''RadSite'''
 +
|https://radsitequality.com/
 +
|-
 +
|'''SNMMI - Society of Nuclear Medicine and Molecular Imaging'''
 +
|http://www.snmmi.org/
 +
|}
  
 
==Funding Agency==
 
==Funding Agency==
 
[[Image:NIBIB Acknowledgement.jpg|400px]]
 
[[Image:NIBIB Acknowledgement.jpg|400px]]

Latest revision as of 13:55, 1 September 2022

Collaborative Efforts

QIBA is grateful for the support of our collaborators.

  • Our society partners help QIBA with the development and implementation of quantitative imaging biomarkers, which are essential to precision medicine and AI tools.
  • The companies offer conformance testing services to help Profile users achieve high-quality quantitative imaging results.

We work together to provide efficient and validated methods for quantifying biomedical imaging results necessary for optimal patient care, clinical research, and new therapy development.



Logos-2.png


Collaboration Highlights

  • EARL II Pilot Study - Ongoing study to assess international imaging site conformance to the QIBA FDG-PET/CT Profile -August 2022
  • RadSite Pilot Study - Ongoing study to assess accredited imaging site conformance to the QIBA FDG-PET/CT Profile - August 2022


Organization link
Accumetra https://accumetra.com/
AIUM - American Institute of Ultrasound in Medicine https://www.aium.org/
CaliberMRI https://qmri.com/
EARL, Research4Life, under the umbrella of the European Association of Nuclear Medicine (EANM) https://www.eanm.org/earl-research4life/
EIBALL - European Imaging Biomarkers Alliance, European Society of Radiology (ESR) https://www.myesr.org/about/organisation/statutory-committees/research-committee
EIBIR - European Institute for Biomedical Imaging https://www.eibir.org/
Invicro https://invicro.com/
ISMRM - International Society for Magnetic Resonance in Medicine https://www.ismrm.org/
Japan Quantitative Imaging Biomarker Alliance (J-QIBA), a part of the Japan Radiological Society http://www.radiology.jp/j-qiba/english/index.html
Prevent Cancer Foundation https://www.preventcancer.org/
RadSite https://radsitequality.com/
SNMMI - Society of Nuclear Medicine and Molecular Imaging http://www.snmmi.org/

Funding Agency

NIBIB Acknowledgement.jpg